Medifast Director Kiai Parsa Buys 94,036 Shares for $1.13M in Open-Market Trades
MED sits 24% above its 52-week low of $9.22.
Summary
Medifast director Kiai Parsa bought 94,036 shares for $1.13 million in open-market trades on November 18-19, raising his indirect stake to 804,221 shares. It is his third disclosed purchase since August, made while the company works through a restructuring and a 19.4% revenue decline.
Key Events · Ownership and Investor Activity · MED
-
Director Buys 94,036 Shares for $1.13M
Kiai Parsa executed four open-market purchases on 2026-11-18 and 2026-11-19 totaling 94,036 shares for $1,133,816, at prices of $12.05-$12.16.
-
Stake Rises to 804,221 Shares
Post-transaction indirect holdings reached 804,221 shares, held through Steamboat Capital Partners Master Fund and Steamboat Capital Partners II.
-
Third Purchase Since August
The purchase follows buys of 43,150 shares in August and 5,557 shares on October 28, continuing a pattern of accumulation by the same director.
-
Buying Into a Restructuring
The purchase comes after Q3 2026 revenue fell 19.4% to $72.0 million and the company posted a $17.5 million net loss including $15.4 million of restructuring charges.
Analysis · MED · Manufacturing
A director has put $1.13 million of real money into the stock over two days at $12.05-$12.16 a share, lifting his indirect holdings to 804,221 shares. This is a meaningful open-market purchase, not an option exercise or grant, and it extends a pattern: Parsa bought 43,150 shares in August and 5,557 shares in late October. The buying comes against a weak backdrop — Q3 revenue fell 19.4% to $72.0 million with a $17.5 million net loss — so the purchase is a director adding to his stake while the business is still shrinking. The main caveat is that the shares sit in Steamboat Capital funds he manages, making this an investment-fund manager's conviction rather than an operating executive's.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MED was trading at $11.48 on NYSE in the Manufacturing sector, with a market capitalization of approximately $128.4M. The 52-week trading range was $9.22 to $13.63. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.